Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor

Figure 2 Relationship between raf kinase inhibitor protein and phosphorylated-extracellular-signal regulated kinase co-expression and prognosis in gastrointestinal stromal tumors. Comparison with the raf kinase inhibitor protein (RKIP)-negative and phosphorylated-extracellular signal-regulated kinase (P-ERK)-positive groups; RKIP high expression group is correlated with a better survival rate and the difference was significant. Log-rank analysis, P = 0.0312.